SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Third quarter trading statement

18 Jan 2024 07:00

RNS Number : 0760A
Cranswick PLC
18 January 2024
 

18 January 2024

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides an update on trading for the 13 weeks to 23 December 2023.

 

Current trading

The interim results announcement dated 21 November 2023 referenced that the strong revenue and earnings growth delivered in the first half of the year had continued through the start of the third quarter. Trading throughout quarter three and particularly during the key Christmas trading period was stronger than anticipated.

 

The Group's Adjusted Profit Before Tax for the year ending 30 March 2024 is now expected to be ahead of the Board's previous expectations.

 

Strong revenue growth during the period was again underpinned by volume growth across all four core UK food categories, as customers and the UK consumer continue to appreciate the affordability, value for money and versatility of our core pork and poultry categories.

 

The Group's expanded pig farming and milling operations, including the recently acquired Elsham Linc business continue to contribute positively.

 

Investment

Our substantial ongoing capital investment programme continues to add capacity, drive automation and deliver efficiency improvements. Investment also continues across our pig farming and feed milling operations with self-sufficiency in UK pigs over 50 per cent.

 

On 8 January 2024 the Company signed an agreement to acquire the entire issued share capital of Froch Foods Holdings Limited ("Froch Foods"). Froch Foods is an added-value processor of predominantly pork and poultry related products. The agreed transaction which is subject to the usual regulatory approvals is expected to complete on 19 January 2024.

 

Financial position

Positive cash generation continues to facilitate effective deployment of capital at pace resulting in strong returns. The Group remains in a robust financial position with committed, unsecured facilities of £250 million providing comfortable headroom.

 

Outlook

The Board is confident that the continued focus on the strengths of the Company, which include its long-standing relationships, breadth and quality of products, robust financial position, and industry leading asset infrastructure, will support the further successful development of Cranswick during the current year and over the longer term.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement for the 53 weeks ending 30 March 2024, on Tuesday 21 May 2024.

 

Adam Couch, CEO of Cranswick, commented:

"The positive momentum generated through the first half of the year continued through the third quarter.

 

"Trading in December was stronger than anticipated as we supported our customers in the lead up to Christmas with exemplary service levels and an innovative range of festive products.

 

"The passion, commitment and professionalism of our teams across the business is a key ingredient in our ongoing successful performance and, again, I would like to thank all our colleagues for their continued dedication and support."

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Elizabeth Kittle

cranswick@powerscourt-group.com

 

Note to editors:

 

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 14,750 people and operates from 22 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 52 weeks to 25 March 2023 showed revenue of £2,323.0m and profit before tax of £139.5m. For more information go to: www.cranswick.plc.uk

 

2. Cranswick is committed to ensuring that its business activities are sustainable from farm-to-fork. Our ambitious sustainability strategy 'Second Nature' has been developed to deliver our vision to become the world's most sustainable meat business. Find out more at: www.thisissecondnature.co.uk

 

3. This announcement is based on information sourced from unaudited management accounts.

 

4. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

5. This announcement contains information that qualified, or may have qualified, as inside information for the purposes of Article 17 of the Market Abuse Regulations (EU) 596/2014 (MAR). The person responsible for making this announcement is Mark Bottomley, Chief Financial Officer.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFEILDIDLIS
Date   Source Headline
24th Nov 20254:59 pmRNSDirector/PDMR Shareholding
3rd Nov 20255:44 pmRNSHolding(s) in Company
3rd Nov 202510:40 amRNSTotal Voting Rights
22nd Oct 20252:06 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSTotal Voting Rights
23rd Sep 20254:31 pmRNSDirector/PDMR Shareholding
17th Sep 20254:43 pmRNSHolding(s) in Company
15th Sep 20258:35 amRNSDirector/PDMR Shareholding
15th Sep 20258:33 amRNSDirector/PDMR Shareholding
11th Sep 202511:30 amRNSTotal Voting Rights
5th Sep 20254:03 pmRNSHolding(s) in Company
4th Sep 20257:56 amRNSHolding(s) in Company
2nd Sep 20255:00 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSHolding(s) in Company
26th Aug 20259:23 amRNSDirector/PDMR Shareholding
26th Aug 20257:07 amRNSHolding(s) in Company
4th Aug 20259:55 amRNSTotal Voting Rights
28th Jul 20252:51 pmRNSPoll Result for 2025 Annual General Meeting
28th Jul 20257:00 amRNSFirst quarter trading statement
24th Jul 20252:46 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSDirector/PDMR Shareholding
22nd Jul 20251:45 pmRNSHolding(s) in Company
9th Jul 20252:58 pmRNSDirector/PDMR Shareholding
8th Jul 20253:23 pmRNSTotal Voting Rights
8th Jul 20253:17 pmRNSDirector/PDMR Shareholding
30th Jun 202510:00 amRNSDirector/PDMR Shareholding
30th Jun 20259:57 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSAnnual Report and Accounts and Notice of AGM
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20253:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:48 pmRNSTotal Voting Rights
27th May 20257:00 amRNSHolding(s) in Company
22nd May 20256:25 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSPreliminary Results
13th May 20252:59 pmRNSHolding(s) in Company
6th May 20254:20 pmRNSHolding(s) in Company
25th Apr 202510:11 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSDirector/PDMR Shareholding
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20258:58 amRNSTotal Voting Rights
26th Mar 20254:08 pmRNSHolding(s) in Company
26th Mar 20252:22 pmRNSDirector/PDMR Shareholding
25th Mar 20254:12 pmRNSDirector/PDMR Shareholding
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.